Cargando…

Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a group of heterogeneous diseases that affects the myocardium. It is also a common familial disease. The symptoms are not common and easy to find. OBJECTIVE: In this paper, we aim to explore and analyze the dysfunctional gene network related to hypert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yunwen, Liu, Cheng, Luo, Jian, Liang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816546/ https://www.ncbi.nlm.nih.gov/pubmed/35126952 http://dx.doi.org/10.1155/2022/8680178

Ejemplares similares

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers
por: Yiu, Kai Hang, et al.
Publicado: (2012)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
por: Viswanathan, Shiv Kumar, et al.
Publicado: (2017)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

Mechanistic complexity of contractile dysfunction in hypertrophic cardiomyopathy
por: Regnier, Michael
Publicado: (2018)

Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy
por: Cui, Hao, et al.
Publicado: (2018)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
por: Chou, Chun, et al.
Publicado: (2021)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
por: Hughes, Rebecca K., et al.
Publicado: (2021)

Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance
por: Liu, Hui-Ting, et al.
Publicado: (2019)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
por: Cordts, Kathrin, et al.
Publicado: (2019)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease?
por: Marsiglia, Júlia Daher Carneiro, et al.
Publicado: (2014)

Multi-factor regulatory network and different clusters in hypertrophic obstructive cardiomyopathy
por: Qin, Xianyu, et al.
Publicado: (2021)

SARC Gene Mutation Is Associated With Myocardial Fibrosis Measured by Histopathology and Cardiac Magnetic Resonance in Patients With Hypertrophic Cardiomyopathy
por: Huang, Manyun, et al.
Publicado: (2023)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy
por: Wang, Xi-Qin, et al.
Publicado: (2023)

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2022)

Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation
por: Li, Shishi, et al.
Publicado: (2018)

Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
por: Coppini, Raffaele, et al.
Publicado: (2014)

Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3
por: Aurensanz Clemente, Esther, et al.
Publicado: (2017)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Sukumolanan, Pratch, et al.
Publicado: (2021)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
por: Ingles, Jodie, et al.
Publicado: (2019)

Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy
por: Fujita, Etsuko, et al.
Publicado: (2013)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
por: Chaves-Markman, Ândrea Virgínia, et al.
Publicado: (2019)

An In Silico Analysis of Troponin I Mutations in Hypertrophic Cardiomyopathy of Indian Origin
por: Ramachandran, Gayatri, et al.
Publicado: (2013)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Shridhar, Puneeth, et al.
Publicado: (2023)

Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, Hannah G., et al.
Publicado: (2018)

Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, H. G., et al.
Publicado: (2019)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3911ut9rg41pvk6muhm7j7ripe